-
Alais S, Soto-Rifo R, Balter V, Gruffat H, Manet E, Schaeffer L, Darlix JL, Cimarelli A, Raposo G, Ohlmann T, 2012: Functional mechanisms of the cellular prion protein (prpc) associated anti-HIV-1 properties[J]. Cell Mol Life Sci, 69, 1331-1352. doi: 10.1007/s00018-011-0879-z
-
Benestad SL, Austbø L, Tranulis MA, Espenes A, Olsaker I, 2012: Healthy goats naturally devoid of prion protein[J]. Vet Res, 43, 87-. doi: 10.1186/1297-9716-43-87
-
Blight KJ, McKeating JA, Rice CM, 2002: Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication[J]. J Virol, 76, 13001-13014. doi: 10.1128/JVI.76.24.13001-13014.2002
-
Bounhar Y, Zhang Y, Goodyer CG, LeBlanc A, 2001: Prion protein protects human neurons against Bax-mediated apoptosis[J]. J Biol Chem, 276, 39145-39149. doi: 10.1074/jbc.C100443200
-
Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W, 1997: The cellular prion protein binds copper in vivo[J]. Nature, 390, 684-687. doi: 10.1038/37783
-
Caruso P, Burla R, Piersanti S, Cherubini G, Remoli C, Martina Y, Saggio I, 2009: Prion expression is activated by adenovirus 5 infection and affects the adenoviral cycle in human cells[J]. Virology, 385, 343-350. doi: 10.1016/j.virol.2008.12.005
-
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M, 1989: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome[J]. Science, 244, 359-362. doi: 10.1126/science.2523562
-
Collins JM, Raphael KL, Terry C, Cartwright EJ, Pillai A, Anania FA, Farley MM, 2015: Hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir[J]. Clin Infect Dis, 61, 1304-1306. doi: 10.1093/cid/civ474
-
Ende AR, Kim NH, Yeh MM, Harper J, Landis CS, 2015: Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: A case report[J]. J Med Case Rep, 9, 164-. doi: 10.1186/s13256-015-0630-8
-
Friebe P, Boudet J, Simorre JP, Bartenschlager R, 2005: Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication[J]. J Virol, 79, 380-392. doi: 10.1128/JVI.79.1.380-392.2005
-
Gabus C, Auxilien S, Péchoux C, Dormont D, Swietnicki W, Morillas M, Surewicz W, Nandi P, Darlix JL, 2001a: The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein[J]. J Mol Biol, 307, 1011-1021. doi: 10.1006/jmbi.2001.4544
-
Gabus C, Derrington E, Leblanc P, Chnaiderman J, Dormont D, Swietnicki W, Morillas M, Surewicz WK, Marc D, Nandi P, 2001b: The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1[J]. J Biol Chem, 276, 19301-19309. doi: 10.1074/jbc.M009754200
-
Gao Z, Zhang H, Hu F, Yang L, Yang X, Zhu Y, Sy MS, Li C, 2016: Glycan-deficient PrP stimulates VEGFR2 signaling via glycosaminoglycan[J]. Cell Signal, 28, 652-662. doi: 10.1016/j.cellsig.2016.03.010
-
Ikeda K, Kawada N, Wang YQ, Kadoya H, Nakatani K, Sato M, Kaneda K, 1998: Expression of cellular prion protein in activated hepatic stellate cells[J]. Am J Pathol, 153, 1695-1700. doi: 10.1016/S0002-9440(10)65683-0
-
Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T, 2007: The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells[J]. J Virol, 81, 588-598. doi: 10.1128/JVI.01534-06
-
Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, 1999: Prions prevent neuronal cell-line death[J]. Nature, 400, 225-226. doi: 10.1038/22241
-
Kwo P, Gane EJ, Peng C-Y, Pearlman B, Vierling JM, Serfaty L, Buti M, Shafran S, Stryszak P, Lin L, 2017: Effectiveness of elbasvir and grazoprevir combination, with or without ribavirin, for treatment-experienced patients with chronic hepatitis C infection[J]. Gastroenterology, 152, 164-175. doi: 10.1053/j.gastro.2016.09.045
-
Lötscher M, Recher M, Lang KS, Navarini A, Hunziker L, Santimaria R, Glatzel M, Schwarz P, Böni J, Zinkernagel RM, 2007: Induced prion protein controls immune-activated retroviruses in the mouse spleen[J]. PLoS One, 2, e1158-. doi: 10.1371/journal.pone.0001158
-
Lai CK, Jeng KS, Machida K, Lai MM, 2008: Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A[J]. J Virol, 82, 8838-8848. doi: 10.1128/JVI.00398-08
-
Li C, Yu S, Nakamura F, Yin S, Xu J, Petrolla AA, Singh N, Tartakoff A, Abbott DW, Xin W, Sy MS, 2009: Binding of pro-prion to filamin a disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer[J]. J Clin Invest, 119, 2725-2736. doi: 10.1172/JCI39542
-
Li Q, Zhang YY, Chiu S, Hu Z, Lan KH, Cha H, Sodroski C, Zhang F, Hsu CS, Thomas E, Liang TJ, 2014: Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle[J]. PLoS Pathog, 10, e1004163-. doi: 10.1371/journal.ppat.1004163
-
Liu T, Li R, Pan T, Liu D, Petersen RB, Wong B-S, Gambetti P, Sy MS, 2002: Intercellular transfer of the cellular prion protein[J]. J Biol Chem, 277, 47671-47678. doi: 10.1074/jbc.M207458200
-
Lohmann V, Körner F, Koch J-O, Herian U, Theilmann L, Bartenschlager R, 1999: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line[J]. Science, 285, 110-113. doi: 10.1126/science.285.5424.110
-
Müller WE, Pfeifer K, Forrest J, Rytik PG, Eremin VF, Popov SA, Schröder HC, 1992: Accumulation of transcripts coding for prion protein in human astrocytes during infection with human immunodeficiency virus[J]. Biochim Biophys Acta, 1139, 32-40. doi: 10.1016/0925-4439(92)90079-3
-
Ma Y, Yates J, Liang Y, Lemon SM, Yi M, 2008: NS3 helicase domains involved in infectious intracellular hepatitis c virus particle assembly[J]. J Virol, 82, 7624-7639. doi: 10.1128/JVI.00724-08
-
Manns MP, Cornberg M, 2013: Sofosbuvir: The final nail in the coffin for hepatitis C?[J]. The Lancet Infect Dis, 13, 378-379. doi: 10.1016/S1473-3099(13)70074-4
-
Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche J, Lehmann S, Launay J, Kellermann O, 2000: Signal transduction through prion protein[J]. Science, 289, 1925-1928. doi: 10.1126/science.289.5486.1925
-
Nakamura Y, Sakudo A, Saeki K, Kaneko T, Matsumoto Y, Toniolo A, Itohara S, Onodera T, 2003: Transfection of prion protein gene suppresses Coxsackievirus B3 replication in prion protein gene-deficient cells[J]. J Gen Virol, 84, 3495-3502. doi: 10.1099/vir.0.19222-0
-
Nikles D, Bach P, Boller K, Merten CA, Montrasio F, Heppner FL, Aguzzi A, Cichutek K, Kalinke U, Buchholz CJ, 2005: Circumventing tolerance to the prion protein (PrP): Vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP[J]. J Virol, 79, 4033-4042. doi: 10.1128/JVI.79.7.4033-4042.2005
-
Odolini S, Lanza P, Angiola A, Zaltron S, Urbinati L, Vavassori A, Nasta P, Festa E, Gargiulo F, Rodella A, 2017: Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection[J]. New Microbiol, 40, 218-220.
-
Paitel E, Fahraeus R, Checler F, 2003: Cellular prion protein sensitizes neurons to apoptotic stimuli through mdm2-regulated and p53-dependent caspase 3-like activation[J]. J Biol Chem, 278, 10061-10066. doi: 10.1074/jbc.M211580200
-
Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang S-L, DeArmond SJ, 1993: Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies[J]. Proc Natl Acad Sci U S A, 90, 10608-10612. doi: 10.1073/pnas.90.22.10608
-
Richt JA, Kasinathan P, Hamir AN, Castilla J, Sathiyaseelan T, Vargas F, Sathiyaseelan J, Wu H, Matsushita H, Koster J, 2007: Production of cattle lacking prion protein[J]. Nat Biotechnol, 25, 132-138. doi: 10.1038/nbt1271
-
Sailer A, Büeler H, Fischer M, Aguzzi A, Weissmann C, 1994: No propagation of prions in mice devoid of PrP[J]. Cell, 77, 967-968. doi: 10.1016/0092-8674(94)90436-7
-
Sakamoto N, Watanabe M, 2009: New therapeutic approaches to hepatitis C virus[J]. J Gastroenterol, 44, 643-. doi: 10.1007/s00535-009-0084-0
-
Simister P, Schmitt M, Geitmann M, Wicht O, Danielson UH, Klein R, Bressanelli S, Lohmann V, 2009: Structural and functional analysis of hepatitis C virus strain JFH1 polymerase[J]. J Virol, 83, 11926-11939. doi: 10.1128/JVI.01008-09
-
Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Kräusslich H-G, Mizokami M, 2005: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome[J]. Nat Med, 11, 791-796. doi: 10.1038/nm1268
-
Yamashita T, Kaneko S, Shirota Y, Qin W, Nomura T, Kobayashi K, Murakami S, 1998: RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the c-terminal region[J]. J Biol Chem, 273, 15479-15486. doi: 10.1074/jbc.273.25.15479
-
Yang L, Zhang Y, Hu L, Zhu Y, Sy MS, Li C, 2014: A panel of monoclonal antibodies against the prion protein proves that there is no prion protein in human pancreatic ductal epithelial cells[J]. Virol Sin, 29, 228-236. doi: 10.1007/s12250-014-3480-4
-
Yang L, Gao Z, Hu L, Wu G, Yang X, Zhang L, Zhu Y, Wong BS, Xin W, Sy MS, 2016: Glycosylphosphatidylinositol anchor modification machinery deficiency is responsible for the formation of pro-prion protein (PrP) in Bxpc-3 protein and increases cancer cell motility[J]. J Biol Chem, 291, 3905-3917. doi: 10.1074/jbc.M115.705830
-
Yang X, Zhang Y, Zhang L, He T, Zhang J, Li C, 2014: Prion protein and cancers[J]. Acta Biochim Biophys Sin (Shanghai), 46, 431-440. doi: 10.1093/abbs/gmu019
-
Zanusso G, Liu D, Ferrari S, Hegyi I, Yin X, Aguzzi A, Hornemann S, Liemann S, Glockshuber R, Manson JC, 1998: Prion protein expression in different species: Analysis with a panel of new mabs[J]. Proc Natl Acad Sci U S A, 95, 8812-8816. doi: 10.1073/pnas.95.15.8812
-
Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV, 2005: Robust hepatitis C virus infection in vitro[J]. Proc Natl Acad Sci U S A, 102, 9294-9299. doi: 10.1073/pnas.0503596102